4//SEC Filing
Pepose Jay 4
Accession 0001140361-23-001516
CIK 0001228627other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:34 PM ET
Size
7.2 KB
Accession
0001140361-23-001516
Insider Transaction Report
Form 4
Pepose Jay
Director
Transactions
- Award
Common Stock
2023-01-11+13,013→ 45,907 total - Award
Stock Option (right to buy)
2023-01-10+33,291→ 33,291 totalExercise: $3.50Exp: 2033-01-09→ Common Stock (33,291 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted shares of common stock in lieu of cash for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $3.07 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 11, 2023.
- [F2]The option will vest with respect to 8,322 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001866191
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 5:34 PM ET
- Size
- 7.2 KB